|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Pneumonia | |||||
| 2 | More general conditions related to this trial | ||||
| Lung Diseases | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Infections | |||||
| 3 | Interventions listed in this trial | ||||
| IV azithromycin | |||||
| Ceftriaxone | |||||
| Azithromycin tablets | |||||
| IV levofloxacin | |||||
| Levofloxacin tablets | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Azithromycin | |||||
| Ofloxacin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Anti-Infective Agents, Urinary | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Nucleic Acid Synthesis Inhibitors | |||||
| Pharmacologic Actions | |||||
| Renal Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Pfizer | |||||